Study to Evaluate the Effect of Nicotinamide Mononucleotide (NMN) As an Adjuvant to Standard of Care (SOC) On Fatigue Associated With COVID-19 Infection

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2021
A Randomized, Double Blind, Placebo-Controlled Study to Evaluate the Effect of Nicotinamide Mononucleotide (NMN) As an Adjuvant to Standard of Care (SOC) On Fatigue Associated with COVID-19 Infection
Epistemonikos ID: 6fc2c428b776998c55d581674a181ce3ec92c2ce
First added on: Jan 05, 2022